Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes

Recruiting N/A Interventional Study
Type 2 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
130 (estimated)
Sponsor
National Taiwan University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Decision cycle for person-centered glycemic management is a new diabetes decision making .It is defined as a purposefully designed holistic care intervention .The goal is to improve the self-care behavior of patients with type 2 diabetes, thereby improving glycated hemoglobin levels and delaying the occurrence of complications.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients diagnosed with type 2 diabetes by a physician. 2. Age: 18 years or above. 3. Glycated hemoglobin (HbA1c ) test value: 7.5-9.0 % 4. No diabetic oral medications, insulin and glucagon-like peptide-1 were replaced in the outpatient when the case was admitted. 5. No preg…
Contacts

Chia-Hui Tsai

886926124093

mtsai0322@gmail.com

CONTACT

Kang-Chih Fan

886972654308

ntuhendocrine@gmail.com

CONTACT